Intragastric botulinum toxin injection: Is it the solution to all gastric ailments?

Saudi J Gastroenterol

Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA.

Published: July 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408734PMC
http://dx.doi.org/10.4103/sjg.sjg_261_22DOI Listing

Publication Analysis

Top Keywords

intragastric botulinum
4
botulinum toxin
4
toxin injection
4
injection solution
4
solution gastric
4
gastric ailments?
4
intragastric
1
toxin
1
injection
1
solution
1

Similar Publications

Intragastric botulinum toxin injection for weight loss: current trends, shortcomings and future perspective.

Clin Endosc

November 2024

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

The administration of botulinum toxin A (BTA) into the gastric wall has emerged as a novel endoscopic bariatric procedure. Although over 20 years have elapsed since the initial human trial of intragastric BTA injection, considerable debate remains surrounding the safety, efficacy, and procedural instructions of this approach. The current literature exhibits discrepancies in the methodologies employed across studies, including differences in the dosage of BTA administered, injection site, number and depth of injections, post-procedural dietary modifications, and follow-up duration.

View Article and Find Full Text PDF

Introduction: Over the past 50 years, the rise in obesity has prompted a search for new treatments. Intragastric injections of botulinum toxin A (BT-A), a safer alternative to surgery, show promise in reducing weight and caloric intake by inducing early satiety. This study examines their efficacy for weight loss.

View Article and Find Full Text PDF

Iatrogenic botulism after intragastric botulinum neurotoxin injections - a major outbreak.

Neurol Res Pract

October 2024

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.

Article Synopsis
  • Intragastric botulinum neurotoxin injections (IBNI) are being used as a weight-loss treatment, but an outbreak of severe iatrogenic botulism occurred in early 2023 in Europe after patients received this treatment in Turkey.
  • A retrospective analysis was conducted on ten patients in Austria and Germany who experienced severe symptoms like double vision, swallowing difficulties, and paralysis after IBNI.
  • Despite the severity of their conditions, all patients were hospitalized, many in intensive care, and ultimately recovered without lasting health issues, underscoring the need for awareness and risk mitigation in medical procedures involving botulinum neurotoxins.
View Article and Find Full Text PDF
Article Synopsis
  • Botulism is a serious condition caused by a toxic protein from the bacteria Clostridium botulinum, leading to paralysis by blocking neurotransmitter release.
  • The poisoning can occur from eating contaminated food, inhaling the toxin, or through skin contact.
  • In 2023, there was an outbreak of iatrogenic botulism in Europe linked to intragastric injections, and this text discusses this phenomenon along with two specific cases from Switzerland.
View Article and Find Full Text PDF

Intragastric botulinum toxin injection directly regulates ghrelin expression via reactive oxygen species and NF-κB signaling.

Life Sci

November 2024

Department of Internal Medicine, School of Medicine, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan; Tong-Yuan Diabetes Center, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. Electronic address:

Aims: One effective clinical strategy to combat obesity is intragastric botulinum toxin (BTX) injection, which increases gastric emptying time and regulates appetite. However, it remains unknown if and how BTX affects ghrelin levels.

Materials And Methods: An obese animal model was established by feeding male mice with high-fat diet (HFD).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!